Clinical Trials Browser

Phase 2/3 × Breast Neoplasms × Eplerenone × Clear all

NCT01708798 2017-01-05

Study of the Effect of Eplerenone on Heart Function in Women Receiving Anthracycline Chemotherapy for Breast Cancer

Phase 2/3 Terminated

Breast Neoplasms, Heart Failure, Diastolic